Showing results (1-10 of 143) with videos related to
Sort By:
Pageof 15
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptionsCurt D FurbergCurrent Controlled Trials in Cardiovascular Medicine|January 25, 2002
A new era in hypertension research: discussing the findings of ALLHATCurt D FurbergCurrent Controlled Trials in Cardiovascular Medicine|January 25, 2002
Withdrawal of cerivastatin from the world marketCurt D Furberg, Bertram PittDrug Safety|November 20, 2016
The Harms of Antipsychotic Drugs: Evidence from Key StudiesThomas J Moore, Curt D FurbergDrug Safety|May 31, 2015
Electronic Health Data for Postmarket Surveillance: A Vision Not RealizedThomas J Moore, Curt D FurbergProgress in Cardiovascular Diseases|January 10, 2012
Approaches to data analyses of clinical trialsCurt D Furberg, Lawrence M FriedmanCurrent Hypertension Reports|November 30, 2014
Plasma renin testing to guide antihypertensive therapyAnthony J Viera, Curt D FurbergJAMA Internal Medicine|October 30, 2013
Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008Thomas J Moore, Curt D FurbergMedical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 29, 2003
Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose toleranceHelmut Sinzinger, Harald Kritz, Curt D FurbergPageof 15